Dow Future Option Chain Free Gift Nifty Live X

IPO Bazar

The Leading Upcoming IPOs Portal

IPO Bazar

The Leading Upcoming IPOs Portal

Sahajanand Medical Technologies IPO GMP Today, Grey Market Premium 2026

Sahajanand Medical Technologies IPO GMP
By NirajPosted on Posted in IPO GMPNo Comments on Sahajanand Medical Technologies IPO GMP Today, Grey Market Premium 2026

The Sahajanand Medical Technologies IPO GMP will be updated regularly as the IPO opening date approaches. The Sahajanand Medical Technologies IPO is open on October 15, 2026, and close on October 19, 2026. Investors can check the latest Sahajanand Medical Technologies IPO Grey Market Premium (GMP) to track unofficial market sentiment ahead of the listing.

The GMP may fluctuate depending on market conditions and investor demand, so the latest figures should be monitored for updates. You can also check the Sahajanand Medical Technologies IPO subscription status to follow the subscription trends during the IPO period.

Sahajanand Medical Technologies Limited (SMT) is an Indian medical technology company that develops, manufactures, and distributes advanced medical devices used in cardiovascular and structural heart procedures. Its product portfolio includes drug-eluting stents, bare-metal stents, balloon catheters, transcatheter aortic valves, occluders, and other interventional medical devices.

The company serves healthcare providers in India and international markets, with manufacturing facilities in India and Thailand. SMT focuses on medical innovation and minimally invasive treatment technologies to support cardiovascular care.

The company products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies, and are widely accepted in over 76 countries across Europe, Asia, and other regions. The global distribution strategy includes direct operations in key European markets (Germany, Spain, France, UK), hybrid models in India (serving hospitals like Narayana Hrudayalaya Limited), and distributor-led entry in markets such as Italy.

Sahajanand Medical Technologies IPO Issue size of ₹475.48 crore, fully offer for sale ₹475.48 and issue price band has been fixed at ₹327 to ₹344 Per Share. The IPO will be listed on October 23, 2026, NSE and BSE.

What is Sahajanand Medical Technologies IPO GMP Today?

  • The Sahajanand Medical Technologies IPO GMP Today ₹35.

Sahajanand Medical Technologies IPO GMP Today Live :

DATE PRICE GMP EST. P/L

Disclaimer: IPO GMP is an unofficial market indicator based on market sentiment and is for informational purposes only; actual listing price may vary.

Apply IPO with Groww
IPO GMP Facts :
  • The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
  • The GMP is also likely to be higher for IPOs that are heavily subscribed.
  • It is important to do your own research before investing in an IPO, regardless of the GMP.
  • The IPO GMP is estimated considering market volatility, demand, supply, underwriting conditions, legal risks, and potential dilution.
  • The Grey Market Premium (GMP) is unofficial and is not regulated by SEBI.
  • Actual listing price may be higher or lower than the estimated listing price.
  • GMP fluctuates continuously until the listing day based on overall stock market sentiment.
  • A negative GMP indicates that the IPO might list at a discount below its issue price.
  • Grey market trading operates entirely on cash/over-the-counter trust and involves no official stock exchange.
  • Institutional subscription numbers (QIBs) often have a direct impact on driving the final GMP trends.
⚠ IPO GMP Disclaimer
  • GMP is not an indicator of the final listing price: Grey Market Premium (GMP) reflects unofficial market sentiment only. The final listing price depends on demand, market conditions, and company fundamentals.
  • GMP can be volatile: GMP may rise or fall significantly before the IPO listing depending on investor sentiment and market activity.
  • No guarantee of listing gains: A high GMP does not guarantee listing profits, and a negative GMP does not necessarily mean the IPO will list at a loss.
  • Investing in IPOs involves risk: Investors should evaluate the company’s financials, valuation, business model, and risk factors before investing.
  • Risk Factors: Market volatility, economic conditions, regulatory changes, and company performance can affect IPO listing performance.
  • Warning: IPO GMP data is purely indicative and should not be considered as a reliable basis for investment decisions. It does not guarantee actual listing performance or returns.
  • Use GMP only as a reference: GMP is unofficial, not regulated by SEBI, and should not be considered investment advice.

Disclaimer: Stock Market Investments are Subject to Market risks, read all scheme Related Document Carefully Before Investing.

Sahajanand Medical Technologies IPO GMP Today, Grey Market Premium 2026

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top